Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Lo

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Open Forum Infectious Diseases|July 14, 2021
Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk PredictionAlexander Goehler, Tzu-Ming Harry Hsu, Jacqueline A Seiglie, et al.
Open Forum Infectious Diseases|March 4, 2015
High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infectionJanet Lo, Eric S Rosenberg, Michael L Fitzgerald, et al.
The Lancet. HIV|October 2, 2015
Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trialJanet Lo, Michael T Lu, Ezinne J Ihenachor, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
Amygdalar Metabolic Activity Independently Associates With Progression of Visceral AdiposityAmorina Ishai, Michael T Osborne, Brian Tung, et al.
Metabolism: Clinical and Experimental|April 21, 2009
Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjectsKathleen V Fitch, Lauren M Guggina, Hester M Keough, et al.
Antiviral Therapy|September 21, 2017
Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIVSuman Srinivasa, Michael T Lu, Kathleen V Fitch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient CohortAlison C Kearns, Fengming Liu, Shen Dai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2018
Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral TherapyBorek Foldyna, Lindsay T Fourman, Michael T Lu, et al.
Journal of the American Heart Association|May 18, 2024
Cardiovascular Risk Estimation Is Suboptimal in People With HIVVirginia A Triant, Asya Lyass, Leo B Hurley, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Open Forum Infectious Diseases|July 14, 2021
Visceral Adiposity and Severe COVID-19 Disease: Application of an Artificial Intelligence Algorithm to Improve Clinical Risk PredictionAlexander Goehler, Tzu-Ming Harry Hsu, Jacqueline A Seiglie, et al.
Open Forum Infectious Diseases|March 4, 2015
High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infectionJanet Lo, Eric S Rosenberg, Michael L Fitzgerald, et al.
The Lancet. HIV|October 2, 2015
Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trialJanet Lo, Michael T Lu, Ezinne J Ihenachor, et al.
The Journal of Clinical Endocrinology and Metabolism|November 2, 2018
Amygdalar Metabolic Activity Independently Associates With Progression of Visceral AdiposityAmorina Ishai, Michael T Osborne, Brian Tung, et al.
Metabolism: Clinical and Experimental|April 21, 2009
Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjectsKathleen V Fitch, Lauren M Guggina, Hester M Keough, et al.
Antiviral Therapy|September 21, 2017
Epicardial adipose tissue volume and cardiovascular risk indices among asymptomatic women with and without HIVSuman Srinivasa, Michael T Lu, Kathleen V Fitch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient CohortAlison C Kearns, Fengming Liu, Shen Dai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 31, 2018
Sex Differences in Subclinical Coronary Atherosclerotic Plaque Among Individuals With HIV on Antiretroviral TherapyBorek Foldyna, Lindsay T Fourman, Michael T Lu, et al.
Journal of the American Heart Association|May 18, 2024
Cardiovascular Risk Estimation Is Suboptimal in People With HIVVirginia A Triant, Asya Lyass, Leo B Hurley, et al.
The Journal of Antimicrobial Chemotherapy|April 24, 2024
Cardiometabolic health in people with HIV: expert consensus reviewRachel L Batterham, Roger J Bedimo, Ricardo S Diaz, et al.
Pageof 9